Arcutis Biotherapeutics Inc

arcutis.com

Arcutis Biotherapeutics (NASDAQ: ARQT) is a biopharmaceutical company focused on developing and commercializing treatments for dermatological conditions. The filing excerpts provided do not contain sufficient detail to describe its revenue model, product portfolio, competitive position, financial results, leadership, or operating geography beyond the company's SEC registration identity. Based solely on the available filing content, no further factual claims about the business can be supported.

Peers: Vericel Corp Avid Bioservices, Inc. Emergent BioSolutions Inc Enanta Pharmaceuticals Inc Kyntra Bio Inc Gossamer Bio Inc Kymera Therapeutics Inc Madrigal Pharmaceuticals Inc Sana Biotechnology Inc

Source: SEC 10-K, filed 2026-02-25

Dive deeper

Financial Snapshot

Revenue

TTM

$464.0M

Gross Margin

TTM

91.13%

Net Income

TTM

$28.52M

Current Assets

2026 Q2

$467.7M

Current Liabilities

2026 Q2

$160.3M

Current Ratio

2026 Q2

291.67%

Total Assets

2026 Q2

$488.5M

Total Liabilities

2026 Q2

$268.0M

Book Value

2026 Q2

$220.6M

Cash

2026 Q2

$34.12M

P/E

TTM

110.5

Free Cash Flow

TTM

$39.15M

Stock Price

Market Cap: $3.1524 Billion